Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (4): 123-127.doi: 10.6040/j.issn.1671-7554.0.2021.1474

Previous Articles    

A case report of Barth syndrome

REN Hong, WANG Wei, LIN Yan, LOU Jianwei, JI Kunqian, ZHAO Yuying, YAN Chuanzhu   

  1. Department of Neurology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Published:2022-04-22

Abstract: Objective To investigate the clinical manifestations, imaging features, muscle pathology and genetic analysis of a patient presenting Barth syndrome(BTHS)with TAZ gene mutation, so as to improve clinician’s understanding of the disease. Methods Clinical and laboratory data of a patient with BTHS were collected and analyzed, and relevant literature was reviewed. Results The patient was a 14-year-old boy presenting with growth retardation since childhood. He was admitted to our hospital due to weakness of limbs for more than two months. Physical examination showed bilateral weakness in trapezius, sternocleidomastoid muscles and limbs. Blood routine examination indicated a decrease in neutrophil count. Urine organic acid analysis revealed elevated 3-methylglutaconicaciduria. Muscle MRI showed abnormal signals on FS T2WI(fat suppression T2 weighted imaging)in both gluteus maximus muscles and muscles around the tibial epiphysis. Muscle pathology showed mild myogenic lesion. Genetic analysis confirmed that the patient and his mother carried mutation c.589G>A in the TAZ gene. Conclusion Barth syndrome is a clinically and genetically heterogeneous disorder with various onset forms. When patients present with inexplicable decreased neutrophils or myocardial involvement, BTHS should be considered. Early diagnosis, symptomatic treatment and supportive care can improve the quality of life for patients.

Key words: Barth syndrome, TAZ gene, Mutation, Cardiolipin

CLC Number: 

  • R746.9
[1] Vreken P, Valianpour F, Nijtmans LG, et al. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome [J]. Biochem Biophys Res Commun, 2000, 279(2): 378-382.
[2] Miller PC, Ren M, Schlame M, et al. A bayesian analysis to determine the prevalence of Barth syndrome in the pediatric population [J]. J Pediatr, 2020, 217: 139-144. doi: 10.1016/j.jpeds.2019.09.074.
[3] Clarke SL, Bowron A, Gonzalez IL, et al. Barth syndrome [J]. Orphanet J Rare Dis, 2013, 8: 23. doi: 10.1186/1750-1172-8-23.
[4] 宋金青, 马艳艳, 丁圆, 等. Barth综合征导致幼儿心内膜弹力纤维增生症的临床特点及其TAZ基因突变[J]. 中华妇幼临床医学杂志(电子版), 2016, 12(5): 535-539. SONG Jinqing, MA Yanyan, DING Yuan, et al. Clinicai characteristics and TAZgene mutation of an infant with endocardial fibroelastosis due to Barth syndrome[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2016, 12(5): 535-539.
[5] Chin TK, Perloff JK, Williams RG, et al. Isolated noncompaction of left ventricular myocardium. A study of eight cases [J]. Circulation, 1990, 82(2): 507-513.
[6] Roberts AE, Nixon C, Steward CG, et al. The Barth syndrome registry: distinguishing disease characteristics and growth data from a longitudinal study [J]. Am J Med Genet a, 2012, 158A(11): 2726-2732.
[7] 石琳, 傅立军, 黄美容, 等. Barth综合征3例临床表现及基因突变分析[J]. 临床儿科杂志, 2015, 33(7): 614-617.
[8] Schlame M, Xu Y. The Function of tafazzin, a mitochondrial phospholipid-lysophospholipid acyltransferase [J]. J Mol Biol, 2020, 432(18): 5043-5051.
[9] Houtkooper RH, Vaz FM. Cardiolipin, the heart of mitochondrial metabolism [J]. Cell Mol Life Sci, 2008, 65(16): 2493-2506.
[10] Takeda A, Sudo A, Yamada M, et al. Eponym: Barth syndrome [J]. Eur J Pediatr, 2011, 170(11):1365-1367.
[11] Aprikyan AA, Khuchua Z. Advances in the understanding of Barth syndrome [J]. Br J Haematol, 2013, 161(3): 330-338.
[12] Zegallai HM, Hatch GM. Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets [J]. Mol Cell Biochem, 2021, 476(3): 1605-1629.
[13] Dudek J, Cheng IF, Chowdhury A, et al. Cardiac-specific succinate dehydrogenase deficiency in Barth syndrome [J]. EMBO Mol Med, 2016, 8(2): 139-154.
[14] Schwall CT, Greenwood VL, Alder NN. The stability and activity of respiratory Complex II is cardiolipin-dependent [J]. Biochim Biophys Acta, 2012, 1817(9): 1588-1596.
[15] Gill AJ. Succinate dehydrogenase(SDH)-deficient neoplasia [J]. Histopathology, 2018, 72(1): 106-116.
[16] Valianpour F, Wanders RJ, Overmars H, et al. Linoleic acid supplemention of Barth syndrome fibroblasts restores cardiolipin levels: Implications for treatment [J]. J Lipid Res, 2003, 44(3): 560-566.
[17] Huang Y, Powers C, Moore V, et al. The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome [J]. Orphanet J Rare Dis, 2017, 12(1): 49.
[18] Wang S, Li Y, Xu Y, et al. AAV gene therapy prevents and reverses heart failure in a murine knockout model of barth syndrome [J]. Circ Res, 2020, 126(8): 1024-1039.
[19] Suzuki-Hatano S, Saha M, Rizzo SA, et al. AAV-Mediated TAZ gene replacement restores mitochondrial and cardioskeletal function in barth syndrome [J]. Hum Gene Ther, 2019, 30(2): 139-154.
[20] Povsic TJ, O’Connor CM, Henry T, et al. A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction [J]. Am Heart J, 2011, 162(4): 654-662.
[21] He Q, Harris N, Ren J, et al. Mitochondria-targeted antioxidant prevents cardiac dysfunction induced by tafazzin gene knockdown in cardiac myocytes [J]. Oxid Med Cell Longev, 2014, 2014: 654198. doi:10.1155/2014/654198.
[1] PAN Pengfei, XU Lisheng, JI Kunqian, WANG Dexiang, LI Yu. Mitochondrial myopathy beginning with respiratory failure: one case and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 54-59.
[2] Benkang SHI,Shouzhen CHEN,Sifeng QU,Yong WANG,Lei LIU. Research progress and clinical characteristics of clinical rapidly progressing prostate cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 110-116.
[3] Huailong ZHAO,Yan LYU,Hong ZHAO,Baotian ZHAO,Ying HAN,Jing PAN,Xiaoman DING,Chunrong WANG,Xiuyun HAN,Lanzheng LIU. Genetic characteristics and molecular variation of human rhinovirus genetype B83 in Jinan [J]. Journal of Shandong University (Health Sciences), 2021, 59(5): 68-72, 81.
[4] SUN Yu, CHEN Na, MA Aihua. A case of congenital disorder of glycosylation caused by SLC35A2 gene mutation [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 113-116.
[5] HUANG Xiuli, LIU Bingju, SUN Lifeng. Activated phosphoinositide 3-kinase δ syndrome caused by a mutation in PIK3CD gene: a case report and literature review [J]. Journal of Shandong University (Health Sciences), 2021, 59(3): 107-112.
[6] WANG Zhengyang, XIA Yan, SHI Kaixuan, TAO Kun, WANG Xiaojie. Effects of Trametinib on PAX8 expression in ovarian cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 23-29.
[7] HU Sicui, SUN Qing, WANG Yibing, SUN Lili, SUI Yanxi, LI Tang. Analysis of CLCNKB gene mutation in two families with Bartter syndrome [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 64-70.
[8] XU Jixi, CHEN Weijian. Diffuse midline glioma with H3 K27M mutation in the spinal cord: a case report [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 96-101.
[9] LIU He, LIU Fuqiang, HOU Xinguo, CHEN Li. A study of 11β-hydroxylase defect induced by a novel CYP11B1 gene mutation in one family [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 85-89.
[10] LU Min, CHEN Yun, DING Botong, CHANG Yali, ZHOU Yawei, ZHAO Aiping, GUO Nongjian. Gene detection and analysis for hemophilia B among populations in Shandong Province [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(3): 87-92.
[11] SUN Jie, MU Xiaoyan, DONG Xueli. Combinational and sequential effect of sunitinib and gemcitabine on K-RAS mutant A549 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(3): 45-49.
[12] ZHU Famei, ZHENG Jiafa, XIE Dinghua, HU Peng. Analysis of SLC26A4 gene mutations in 5 families associated with enlarge vestibular aqueduct syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(10): 90-95.
[13] SUN Jin, HAN Bo, WEI Mei-li, YANG Wen-wei, WANG Jie-zhong, LIU Yong-jiao. Mutation screening of TFAP2B gene in children with patent ductus arteriosus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 72-75.
[14] LIU Chen-fan1, WANG Zhen-ying2, SONG Huai-dong3, PAN Chun-ming3, ZHANG Li2. Mutation screening of candidate genes causing disseminated superficial porokeratosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(1): 93-97.
[15] WANG Xue1,2, YANG Kun3, HAN Tao1, LI Wen-na1, WEI Kun-kun1, LIU Qi-ji2, LIU Xue-wu1. NOTCH 3 heterozygous mutation causing cerebral autosomal dominant
arteriopathy with subcortical infarcts and leukoencephalopathy 
in a Chinese family
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 63-.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!